Forbion

Boston, Massachusetts
Firm Location:Boston, Massachusetts • Munich, Germany • Amsterdam, Netherlands • Netherlands • Denmark • Cambridge, United Kingdom • Naarden, Netherlands
Forbion Team
Photo of Philip Astley-Sparke, Venture Partner at Forbion
Philip Astley-Sparke
Forbion·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT
Photo of Juliette Audet, Partner at Forbion
Juliette Audet
Forbion·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in BioTech, Investors in Pharmaceuticals
Photo of Marco Boorsma, General Partner at Forbion
Marco Boorsma
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Naarden (Netherlands), Investors in Amsterdam (Netherlands)
Investors in BioTech, Investors in Diagnostics, Investors in Manufacturing, Investors in Pharmaceuticals
Photo of Jasper Bos, General Partner at Forbion
Jasper Bos
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Antoine Boulanger Piette, Associate at Forbion
Antoine Boulanger Piette
Forbion·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT
Photo of Audrey Cacaly, Senior Associate at Forbion
Audrey Cacaly
Forbion·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Dmitrij Hristodorov, Partner at Forbion
Dmitrij Hristodorov
Forbion·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Munich (Germany)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Wouter Joustra, General Partner at Forbion
Wouter Joustra
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech
Photo of Dirk Kersten, General Partner at Forbion
Dirk Kersten
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT
Photo of Nanna Luneborg, General Partner at Forbion
Nanna Luneborg
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denmark
Investors in BioTech, Investors in Health & Hospital Services
Photo of Geert-Jan Mulder, Managing Partner at Forbion
Geert-Jan Mulder
Forbion·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Holger Reithinger, General Partner at Forbion
Holger Reithinger
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Munich (Germany)
Investors in BioTech, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Rogier Rooswinkel, Partner at Forbion
Rogier Rooswinkel
Forbion·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech, Investors in Health & Hospital Services
Photo of Patrick Round, Venture Partner at Forbion
Patrick Round
Forbion·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (United Kingdom)
Investors in BioTech, Investors in Pharmaceuticals
Photo of Sander Slootweg, Managing Partner at Forbion
Sander Slootweg
Forbion·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in BioTech, Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Marc-Olivier Turgeon, Analyst at Forbion
Marc-Olivier Turgeon
Forbion·Analyst
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech
Photo of Martien van Osch, Managing Partner at Forbion
Martien van Osch
Forbion·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech, Investors in Medical Devices, Investors in Pharmaceuticals